
A retrospective cohort study found that menopausal hormone therapy (MHT) was not associated with an increased risk of melanoma in menopausal Korean women. However, tibolone and combined estrogen plus progestin by the manufacturer (COPM) were associated with a reduced risk of non-melanoma skin cancer (NMSC), while other hormone groups showed no significant effect on NMSC risk.
Like
Save
Share